Mitigating the economic burden of GnRH agonist therapy for progestogen-resistant endometriosis: why not?

STUDY QUESTION: Is it possible to reduce the cost of GnRH agonist treatment for endometriosis by using non-standard dosing regimens? SUMMARY ANSWER: An extended-interval dosing regimen of a 3.75 mg depot formulation of triptorelin injected every 6 weeks instead of every 4 weeks reduces the cost by o...

Descripción completa

Detalles Bibliográficos
Autores principales: Vercellini, Paolo, Bandini, Veronica, Buggio, Laura, Barbara, Giussy, Berlanda, Nicola, Dridi, Dhouha, Frattaruolo, Maria Pina, Somigliana, Edgardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067151/
https://www.ncbi.nlm.nih.gov/pubmed/37016694
http://dx.doi.org/10.1093/hropen/hoad008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067151/
https://www.ncbi.nlm.nih.gov/pubmed/37016694
http://dx.doi.org/10.1093/hropen/hoad008

Ejemplares similares